Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.51 – $3.35
0% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Revenue | $413.9K | $3.2M | $3.8M | $7.4M | $4.3M |
| Cost of revenue | $94.2K | $1.0M | $591.9K | $173.3K | $91.1K |
| Gross profit | $319.6K | $2.2M | $3.2M | $7.2M | $4.2M |
| Gross margin | 77.2% | 69.0% | 84.5% | 97.7% | 97.9% |
| R&D | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$378.4K | −$7.6M | $29.2K | $2.0M | $552.7K |
| EBITDA | −$375.7K | −$7.5M | $99.1K | $2.0M | $851.8K |
| Net income | −$328.6K | −$7.5M | −$39.1K | $1.3M | $460.4K |
| Net margin | -79.4% | -232.2% | -1.0% | 17.0% | 10.8% |
| EPS (diluted) | -0.00 | -0.25 | -0.00 | 0.04 | 0.02 |
Annual figures · source: Financial Modeling Prep
LONGDUODUO CO LTD
No one on the platform currently holds LDDD.
No tracked institution reports a position in LDDD as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-09-27 | 1-for-10reverse |
No one on the platform has traded LDDD yet.
| $44M |
| — |
| RBOTVicarious Surgical Inc. | $0.16 | -10.86% | $1M | — |
| RLYBRallybio Corporation | $15.95 | -0.68% | $93M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.